Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.6B | 12.2B | 11.9B | 11.6B |
Cost of revenue | 8.4B | 9.7B | 9.3B | 9.1B |
Gross profit | 2.2B | 2.5B | 2.6B | 2.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.4B | 1.4B | 1.3B | 1.4B |
Other operating expenses | 634M | -1.2B | 411M | 450M |
Operating income | 685M | 1.4B | 1.1B | 1.1B |
Non operating interest income | ||||
Income | 173M | 43M | 62M | 225M |
Expense | 278M | 149M | 216M | 335M |
Other income expense | — | — | — | — |
Pretax income | 647M | 893M | 895M | 737M |
Tax provision | 181M | 151M | 170M | 152M |
Net income | 466M | 742M | 725M | 584M |
Basic EPS | 0.9 | — | — | — |
Diluted EPS | 0.9 | — | — | — |
Basic average shares | 501.1M | — | — | — |
Diluted average shares | 501.1M | — | — | — |
EBITDA | 1.7B | 3.0B | 1.9B | 1.9B |
Net income from continuing op. | 647M | 893M | 895M | 737M |
Minority interests | 0 | 2M | -2M | 1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |